Patents by Inventor Ana Mateo Herranz

Ana Mateo Herranz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070254869
    Abstract: Compounds of formula I wherein n, m, p, q, y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.
    Type: Application
    Filed: October 7, 2004
    Publication date: November 1, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Guoqing Cao, Ana Escribano, Maria Fernandez, Todd Fields, Douglas Gernert, Christopher Cioffi, Robert Herr, Nathan Mantlo, Eva Martin De La Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiaodong Wang
  • Publication number: 20070244095
    Abstract: Compounds of formula I wherein n, m, p, q, Y, R1 R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
    Type: Application
    Filed: June 23, 2005
    Publication date: October 18, 2007
    Inventors: Xinchao Chen, Christopher Cioffi, Sean Dinn, Ana Escribano, Maria Fernandez, Todd Fields, Robert Herr, Nathan Mantlo, Eva Martin De La Nava, Ana Mateo-Herranz, Saravanan Parthasarathy, Xiaodong Wang
  • Publication number: 20070208003
    Abstract: The present invention discloses compounds of formula I wherein A, n, m, j, q, y, W, X, Y, Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
    Type: Application
    Filed: March 17, 2005
    Publication date: September 6, 2007
    Inventors: Michael Bell, Guoqing Cao, Ana Escribano, Maria Fernandez, Nathan Mantlo, Eva Martin de la Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiadong Wang
  • Publication number: 20070173526
    Abstract: The present invention discloses compounds of formula (I) wherein A, n, q, K, W, X, Y; Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
    Type: Application
    Filed: March 17, 2005
    Publication date: July 26, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Michael Bell, Guoqing Cao, Ana Escribano, Maria Fernandez, Peter Lander, Nathan Mantlo, Eva Martin de la Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiaodong Wang
  • Publication number: 20070054912
    Abstract: Compounds comprising an aza-bicyclic portion and an aromatic portion linked via an optionally oxidized sulphur atom are disclosed. The compounds disclosed are useful for the treatment of dysfunctions of the central and autonomic nervous systems.
    Type: Application
    Filed: November 9, 2006
    Publication date: March 8, 2007
    Inventors: Peter Astles, Stephen Baker, Rowena Cube, Jose Martinez-Perez, Ana Mateo Herranz, Jean Vernier, Colin Dell, Sonia Gutierrez, Lourdes Prieto, Martine Keenan, Adam Sanderson, Colin Smith
  • Publication number: 20050182088
    Abstract: The present invention relates to compounds that modulate neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine and norepinephrine. More particularly, the present invention relates to thio-bridged aryl compounds that are capable of modulating acetylcholine receptors and pharmaceutical compositions comprising such compounds. The compounds disclosed are useful for the treatment of dysfunctions of the central and autonomic nervous systems.
    Type: Application
    Filed: July 29, 2002
    Publication date: August 18, 2005
    Inventors: Peter Astles, Stephen Baker, Rowena Cube, Jose Martinez-Perez, Ana Mateo Herranz, Jean Vernier, Colin Dell, Sonia Gutierrez, Lourdes Prieto, Martine Keenan, Adam Sanderson, Colin Smith